Therefore, certain inflammatory biomarkers, such as interleukin (IL)-1, IL-18, IL-6, tumor necrosis factor-alpha (TNF-α), and C-reactive protein, among others, have been reported to be used as possible predictors and therapeutic targets for CKD [16]. This evidence concerns the gene TNF and chronic kidney disease.